OvaScience Can't Duck IVF Treatment Suit, Shareholders Say
Shareholders suing OvaScience Inc. for allegedly misrepresenting the success of its fertility treatment have urged a Massachusetts federal court to keep their proposed class action alive, saying they have sufficiently detailed...To view the full article, register now.
Already a subscriber? Click here to view full article